CBD
ADVERTORIAL
SELLING CbD IS PROFITAbLE, bUT WHAT AbOUT PRESCRIbING MEDICAL CANNAbIS? NOW YOU CAN DO bOTH!
Pharmacists are held to higher standards than retailers, so it falls on you to have a clearly-defined duty of care to your patients. Many cannabis containing food supplement products are not what they say they are.
The market is exploding with poor quality imports - products that contain THC when they should not - and products that actually do not contain any cannabinoids!
It is clear to us - and our legal
teams - that pharmacies selling these products without the required due diligence, knowledge or training are in breach of their code of ethics. More importantly, it is highly likely the sale is non compliant with the law and would not be insurable.
Does the product even have a leaflet?
Have you checked the CofA? What about drug interactions? (There are many!) Through the CbD Wellness wholesale and training model, we have produced basic healthcare training for pharmacists and technicians to allow for a safe and compliant sale of a cannabidiol in various forms in a retail environment.
These are food supplements that have been vetted and are assessed with GMP and GDP quality standards. As a retailer, this is an opportunity for you to make very high margins, while allowing patients to safely obtain cannabis containing products to try.
Products are available direct from us or Ethigen, and training/certification is available via our head office.
www.cbdwellness.co.uk (0141 404 6255).
We do not believe this is where it ends, however. Pharmacy has the
ability to take charge of this molecule and deliver real benefit to its patients.
We have put together a team of doctors, consultants and pharmacists who have ten years’ experience of dealing with patients who wish to try cannabinoids.
We have been working with some of the largest international medical cannabis pharmacy chains, and have put together a clinic model – designed to work just like a PGD – which allows you to run a cannabis clinic in your own pharmacy, providing everything from pure cannabidiol to THC- containing products and unlicensed medicines.
In doing so, we have formed Canidol Pharmaceutics, who manufacture and conduct primary research on cannabinoids and endocannabinoids only available through pharmacy. This allows you – as a pharmacist - to start prescribing medical cannabis following research protocols for a number of conditions including chronic pain.
You do not need to be an IP or prescriber to run a private clinic. You can sign up for more information online at www.
ukcannabisclinic.com
Cannabinoids need to be taken back into the hands of healthcare professionals and away from vape shops, supermarkets and corner stores.
Pharmacists are in an ideal place to do this and should take action straight away.
THERE HARDLY SEEMS TO bE A DAY WHEN CANNAbIS-bASED MEDICINES HAVEN’T FEATURED IN THE MEDIA IN SOME WAY...
CbD: ALL YOU NEED TO KNOW
F
rom the recent high-profilecase of thirteen-year-old billy Caldwell, who was denied legal
access to the cannabis oil that helps to control his epileptic seizures, to various studies that have shown that cannabinoid (CbD) treatments can help a wide range of ills, from anxiety to epilepsy, from inflammation to pain – the subject of cannabis-based medicines has not only dominated the headlines, but has certainly divided opinion.
WHY IS THIS? Well, cannabinoids are the chemicals which are found naturally in marijuana plants. Even though they come from marijuana plants, however, cannabinoids don’t create any form of ‘high’ or any form of intoxication – that is caused by another cannabinoid known as THC. (billy Caldwell’s medicine, for example, was illegal because it contained THC, the psychoactive compound that affects those who smoke cannabis.)
These new treatments, however, use the less mind-bending cannabinoid known as CbD.
CbD is extracted from marijuana plants in either oil or powder format. It can be mixed into creams or gels and can then be put into capsules and taken orally, or rubbed onto the skin in topical format.
WHAT IS USED FOR? Anxiety relief: researchers think that CbD may be able to help patients manage anxiety because it has the potential to change the way that the brain’s receptors respond to
serotonin, a chemical that is primarily linked to mental health. One recent study, for example, found that a 600mg dose of CDb helped people who suffered from social anxiety to speak in public.
Prevention or reduction of seizures: the case of billy Caldwell highlighted the fact that CbD may be a possible treatment for epilepsy. A study carried out in 2016 involved more than 200 people with epilepsy who, until the study, had been given anti- epilepsy medications. For the study, they were given an additional oral dose of 2-5mg of CbD. After twelve weeks of monitoring, participants had 36.5 fewer seizures per month, which was very positive news, but, conversely, severe adverse effects were recorded in twelve per cent of the study group.
Treatment of acne: it’s thought that CbD oil may prevent activity in sebaceous glands - the glands, which are responsible for producing sebum, over-production of which can lead to acne.
Pain relief: inflammation is behind many patients’ pain issues and so researchers think that the effects of CbD oil on the brain’s receptors may help patients to manage their pain. Neuroprotective: at present, researchers are currently looking at two types of cannabinoid receptor with regard to possible treatment of pharmacological treatment of disease. These receptors are Cb1 and Cb2 and both have wide expression through the central nervous and immune systems. Cb1 receptors are attached to by THC, forming a psychoactive >
PHARMACY IN FOCUS - 23
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
